Malaysia
Industry
BMI View: Despite negative public perceptions, free trade agreement (FTA) talks with the EU will boost Malaysia's overall economy. Multinational pharmaceutical companies will also benefit....
2011-05-16Industry
BMI View: Attention deficit hyperactivity disorder (ADHD) represents a small but growing opportunity for pharmaceutical companies operating in South East Asia. The prevalence of the...
2011-05-04Industry
BMI View: SIRO Clinpharma's new operations in Malaysia will allow it to better serve new and existing clients in Asia. The Malaysian government has been actively supporting pharmaceutical...
2011-04-26Industry
BMI View: Malaysia's new patient-centric service of sending medicine by post is an innovative approach by the government to provide healthcare directly to consumers at their homes....
2011-04-12Industry
BMI View: Malaysia's pharmaceutical market is a moderate but improving prospect for multinational drugmakers. Supported by an expanding economy and relative political stability, combined...
2010-11-10Economy
Developed state underperformance remains a recurring theme within our Industry analysis. We remain concerned about US labour market weakness and its impact, particularly on consumer...
2010-09-28Industry
BMI Core View: The addition of Western pharmaceuticals to traditional medicines is a minor but growing trend. Indigenous or folk remedies play an important role in many cultures and...
2010-09-10Industry
Malaysian drugmaker and medicine distributor Pharmaniaga has had a turbulent start to 2010. Following the February release of financial results that BMI described as 'disappointing',[1]...
2010-03-04
